Balyasny Asset Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,024,139	Closed	-$15.3M	–	3041
2023 Q3	$15.3M	Sell	1,024,139 -690,679	-40%	-$9.16M	0.04%	687
2023 Q2	$18.8M	Sell	1,714,818 -242,250	-12%	-$2.26M	0.05%	555
2023 Q1	$17.1M	Buy	1,957,068 +1,901,769	+3,439%	+$15.2M	0.06%	579
2022 Q4	$347K	Buy	+55,299	New	+$210K	﹤0.01%	1950
2019 Q3	–	Sell	-80,264	Closed	-$575K	–	1731
2019 Q2	$575K	Buy	80,264 +27,017	+51%	+$306K	﹤0.01%	1199
2019 Q1	$707K	Sell	53,247 -190,819	-78%	-$2.03M	0.01%	1108
2018 Q4	$1.92M	Buy	+244,066	New	+$2.32M	0.02%	727
2015 Q4	–	Sell	-12,600	Closed	-$24K	–	1548
2015 Q3	$24K	Sell	12,600 -1,715	-12%	-$4.67K	﹤0.01%	1111
2015 Q2	$39K	Buy	+14,315	New	+$58.8K	﹤0.01%	1109